Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI) has a higher price-to-earnings ratio of 6.64x compared to its average ratio, Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 1 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”
The average price suggested by analysts for MRVI is $18.82, which is $5.96 above the current market price. The public float for MRVI is 109.46M, and currently, shorts hold a 6.64% of that float. The average trading volume for MRVI on May 26, 2023 was 2.29M shares.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
MRVI) stock’s latest price update
The stock price of Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI) has dropped by -1.34 compared to previous close of 13.40. Despite this, the company has seen a gain of 3.69% in its stock price over the last five trading days.
MRVI’s Market Performance
Maravai LifeSciences Holdings Inc. (MRVI) has experienced a 3.69% rise in stock performance for the past week, with a 0.00% drop in the past month, and a -7.94% drop in the past quarter. The volatility ratio for the week is 6.38%, and the volatility levels for the past 30 days are at 9.23% for MRVI. The simple moving average for the last 20 days is -1.99% for MRVI’s stock, with a simple moving average of -19.80% for the last 200 days.
MRVI Trading at -3.96% from the 50-Day Moving Average
After a stumble in the market that brought MRVI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.46% of loss for the given period.
Volatility was left at 9.23%, however, over the last 30 days, the volatility rate increased by 6.38%, as shares sank -1.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.82% lower at present.
During the last 5 trading sessions, MRVI rose by +3.69%, which changed the moving average for the period of 200-days by -47.95% in comparison to the 20-day moving average, which settled at $13.48. In addition, Maravai LifeSciences Holdings Inc. saw -7.62% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MRVI
Current profitability levels for the company are sitting at:
- +66.33 for the present operating margin
- +80.55 for the gross margin
The net margin for Maravai LifeSciences Holdings Inc. stands at +24.94. The total capital return value is set at 46.51, while invested capital returns managed to touch 23.09.
Based on Maravai LifeSciences Holdings Inc. (MRVI), the company’s capital structure generated 97.89 points at debt to equity in total, while total debt to capital is 49.47. Total debt to assets is 23.38, with long-term debt to equity ratio resting at 95.74. Finally, the long-term debt to capital ratio is 48.38.
When we switch over and look at the enterprise to sales, we see a ratio of 2.33, with the company’s debt to enterprise value settled at 0.14. The receivables turnover for the company is 6.68 and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.70.
Conclusion
In conclusion, Maravai LifeSciences Holdings Inc. (MRVI) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
